Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 167

Similar articles for PubMed (Select 22397851)

1.

Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis.

Madhuvrata P, Singh M, Hasafa Z, Abdel-Fattah M.

Eur Urol. 2012 Nov;62(5):816-30. doi: 10.1016/j.eururo.2012.02.036. Epub 2012 Feb 25. Review.

PMID:
22397851
2.

Which anticholinergic drug for overactive bladder symptoms in adults.

Madhuvrata P, Cody JD, Ellis G, Herbison GP, Hay-Smith EJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD005429. doi: 10.1002/14651858.CD005429.pub2. Review.

PMID:
22258963
3.

Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.

Rai BP, Cody JD, Alhasso A, Stewart L.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD003193. doi: 10.1002/14651858.CD003193.pub4. Review.

PMID:
23235594
4.

Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.

Stöhrer M, Mürtz G, Kramer G, Schnabel F, Arnold EP, Wyndaele JJ; Propiverine Investigator Group.

Eur Urol. 2007 Jan;51(1):235-42. Epub 2006 May 2.

PMID:
16698176
5.

Which anticholinergic drug for overactive bladder symptoms in adults.

Hay-Smith J, Herbison P, Ellis G, Morris A.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD005429. Review. Update in: Cochrane Database Syst Rev. 2012;1:CD005429.

PMID:
16034974
7.

Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity.

Sussman D, Patel V, Del Popolo G, Lam W, Globe D, Pommerville P.

Neurourol Urodyn. 2013 Mar;32(3):242-9. doi: 10.1002/nau.22293. Epub 2012 Sep 10.

PMID:
22965657
8.

OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology.

Ginsberg D, Cruz F, Herschorn S, Gousse A, Keppenne V, Aliotta P, Sievert KD, Brin MF, Jenkins B, Thompson C, Lam W, Heesakkers J, Haag-Molkenteller C.

Adv Ther. 2013 Sep;30(9):819-33. doi: 10.1007/s12325-013-0054-z. Epub 2013 Sep 27. Erratum in: Adv Ther. 2014 Feb;31(2):242.

9.

Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury.

Chen G, Liao L.

Int Urol Nephrol. 2011 Sep;43(3):655-62. doi: 10.1007/s11255-010-9873-x. Epub 2010 Nov 26.

PMID:
21110094
10.

Anticholinergic drugs versus placebo for overactive bladder syndrome in adults.

Nabi G, Cody JD, Ellis G, Herbison P, Hay-Smith J.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003781. Review.

PMID:
17054185
11.

Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity.

Gamé X, Khan S, Panicker JN, Kalsi V, Dalton C, Elneil S, Hamid R, Dasgupta P, Fowler CJ.

BJU Int. 2011 Jun;107(11):1786-92. doi: 10.1111/j.1464-410X.2010.09791.x. Epub 2010 Oct 29.

PMID:
21040367
12.

Treatments for overactive bladder: focus on pharmacotherapy.

Geoffrion R; Society of Obstetricians and Gynaecologists of Canada.

J Obstet Gynaecol Can. 2012 Nov;34(11):1092-101.

PMID:
23231848
13.

Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.

Cruz F, Herschorn S, Aliotta P, Brin M, Thompson C, Lam W, Daniell G, Heesakkers J, Haag-Molkenteller C.

Eur Urol. 2011 Oct;60(4):742-50. doi: 10.1016/j.eururo.2011.07.002. Epub 2011 Jul 13.

PMID:
21798658
14.

Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.

Karsenty G, Denys P, Amarenco G, De Seze M, Gamé X, Haab F, Kerdraon J, Perrouin-Verbe B, Ruffion A, Saussine C, Soler JM, Schurch B, Chartier-Kastler E.

Eur Urol. 2008 Feb;53(2):275-87. Epub 2007 Oct 16. Review.

PMID:
17988791
15.
16.

Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults.

Alhasso AA, McKinlay J, Patrick K, Stewart L.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003193. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD003193.

PMID:
17054163
17.

Re: Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis.

Wein AJ.

J Urol. 2013 Nov;190(5):1815-6. doi: 10.1016/j.juro.2013.07.090. Epub 2013 Aug 2. No abstract available.

PMID:
24120792
18.

Trospium chloride in patients with neurogenic detrusor overactivity: is dose titration of benefit to the patients?

Menarini M, Del Popolo G, Di Benedetto P, Haselmann J, Bödeker RH, Schwantes U, Madersbacher H; TcP128-Study Group.

Int J Clin Pharmacol Ther. 2006 Dec;44(12):623-32.

PMID:
17190372
19.
20.

Efficacy, tolerability and safety of propiverine hydrochloride in children and adolescents with congenital or traumatic neurogenic detrusor overactivity--a retrospective study.

Grigoleit U, Mürtz G, Laschke S, Schuldt M, Goepel M, Kramer G, Stöhrer M.

Eur Urol. 2006 Jun;49(6):1114-20; discussion 1120-1. Epub 2006 Mar 3.

PMID:
16542772
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk